Management of Acquired Bleeding Problems in Cancer Patients

被引：2

作者：

DeLoughery, Thomas G. ^{[1
,2
,3
,4
,5
]}

机构：

[1] Oregon Hlth & Sci Univ, Dept Med, Div Hematol, Portland, OR 97201 USA

[2] Oregon Hlth & Sci Univ, Dept Med, Div Med Oncol, Portland, OR 97201 USA

[3] Oregon Hlth & Sci Univ, Dept Pathol, Div Lab Med, Portland, OR 97201 USA

[4] Oregon Hlth & Sci Univ, Dept Pediat, Div Hematol, Portland, OR 97201 USA

[5] Oregon Hlth & Sci Univ, Dept Pediat, Div Med Oncol, Portland, OR 97201 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2010年 / 24卷 / 03期

关键词：

Bleeding; Cancer; Leukemia; Myeloma; Amyloid; Disseminated intravascular coagulation; THROMBOTIC THROMBOCYTOPENIC PURPURA; HEMOLYTIC-UREMIC SYNDROME; BONE-MARROW TRANSPLANTATION; RECOMBINANT FACTOR-VIIA; HEPARIN-INDUCED THROMBOCYTOPENIA; DISSEMINATED INTRAVASCULAR COAGULATION; ACUTE MYOCARDIAL-INFARCTION; OF-AMERICAN-PATHOLOGISTS; VON-WILLEBRAND-SYNDROME; ACTIVATED FACTOR-VII;

D O I：

10.1016/j.hoc.2010.03.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Cancer patients can have acquired bleeding problems for many reasons. In this review, an approach to the evaluation and management of the bleeding patient is discussed. Specific issues including coagulation defects, thrombocytopenia, platelet dysfunction, and bleeding complications of specific hematological malignancies due to anticoagulation, are discussed.

引用

页码：603 / +

页数：23

共 117 条

[1] Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors
Abshire, T
Kenet, G
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (06) : 899 - 909
[2] Treatment of warfarin-associated intracerebral hemorrhage:: Literature review and expert opinion
Aguilar, Maria I.
Hart, Robert G.
Kase, Carlos S.
Freeman, William D.
Hoeben, Maj Barbara J.
Garcia, Rosa C.
Ansell, Jack E.
Mayer, Stephan A.
Norrving, Bo
Rosand, Jonathan
Steiner, Thorsten
Wijdicks, Eelco F. M.
Yamaguchi, Takenori
Yasaka, Masahiro
[J]. MAYO CLINIC PROCEEDINGS, 2007, 82 (01) : 82 - 92
[3] UREMIA AS A CAUSE OF BLEEDING
ANDRASSY, K
RITZ, E
[J]. AMERICAN JOURNAL OF NEPHROLOGY, 1985, 5 (05) : 313 - 319
[4] Haemostatic problems in acute promyelocytic leukaemia
Arbuthnot, Carolina
Wilde, Jonathan T.
[J]. BLOOD REVIEWS, 2006, 20 (06) : 289 - 297
[5] Current concepts - Drug-induced immune thrombocytopenia
Aster, Richard H.
Bougie, Daniel W.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (06) : 580 - 587
[6] Current management of acquired factor VIII inhibitors
Barnett, Brian
Kruse-Jarres, Rebecca
Leissinger, Cindy A.
[J]. CURRENT OPINION IN HEMATOLOGY, 2008, 15 (05) : 451 - 455
[7] IMPROVED SURVIVAL IN THROMBOTIC THROMBOCYTOPENIC PURPURA HEMOLYTIC UREMIC SYNDROME - CLINICAL-EXPERIENCE IN 108 PATIENTS
BELL, WR
BRAINE, HG
NESS, PM
KICKLER, TS
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (06) : 398 - 403
[8] Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization
Berkowitz, SD
Sane, DC
Sigmon, KN
Shavender, JH
Harrington, RA
Tcheng, JE
Topol, EJ
Califf, RM
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (02) : 311 - 319
[9] Berkowitz SD, 1997, CIRCULATION, V95, P809
[10] Evidence for the use of recombinant factor VIIa in the prevention and treatment of bleeding in patients without hemophilia
Birchall, Janet
Stanworth, Simon J.
Duffy, Michael R.
Doree, Carolyn J.
Hyde, Christopher
[J]. TRANSFUSION MEDICINE REVIEWS, 2008, 22 (03) : 177 - 187

← 1 2 3 4 5 6 7 8 9 10 →